Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
110 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global amyotrophic lateral sclerosis treatment market size is expected to reach USD 885.5 million by 2026, according to a new report by Grand View Research. Some of the key factors driving the market include growing awareness about ALS, increasing incidence rate, and rising geriatric population. However, the cost associated with ALS treatment is high, which may hinder the market growth during the forecast period. Currently, no cure is available for ALS and treatments such as medications and stem cell therapies can only help to slow down the disease progression, manage the symptoms, and prevent unnecessary complications. Furthermore, inclination towards a sedentary lifestyle among the geriatric population increases the risk of developing the disorder that increases the demand for new targeted treatment options and therapeutic approaches. According to the U.S. Department of Health Resources & Services, the estimated prevalence of amyotrophic lateral sclerosis in the U.S. was 5.2 per 100,000 people and 16,583 cases of ALS were reported in 2015. Among the treatments, the medications acquired the largest market share in 2018 and is expected to dominate the ALS market over the forecast period. Currently, only two drugs have been approved for use in ALS treatment, Rilutek (riluzole) and Radicava (edaravone). Nuedexta (dextromethorphan/quinidine) in another drug used in ALS treatments, however, it has been approved to treat the pseudobulbar affect (PBA), a comorbidity of ALS. North America held the leading position in the amyotrophic lateral sclerosis market in 2018, while Asia Pacific is projected to grow the fastest among all regions through the forecast period. Further key findings from the study suggest: • Medications held the largest market share in the treatment segment. Although, there is no cure for ALS, the approved medications such as riluzole and edaravone help in managing symptoms and delaying the disease progression. • Stem cell therapy is expected to demonstrate the highest CAGR among the treatment over the forecast period due to the increasing demand for new approaches and advanced treatment options • Asia Pacific regional market is projected to demonstrate the fastest growth during the forecast period due to rising disposable income and improving healthcare infrastructure • Some of the major companies operating in this market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F. Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, and Ionis Pharmaceuticals, Inc.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR's internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Amyotrophic Lateral Sclerosis Treatment Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.2 Market Restraint Analysis
3.4.3 Industry challenges
3.5 Amyotrophic Lateral Sclerosis Treatment Market Analysis Tools
3.5.1 Industry analysis - Porter's
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Technology landscape
3.5.2.5 Legal Landscape
3.5.3 Major deals and strategic alliances analysis
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Technology collaborations
3.5.3.5 Strategic Divestments
3.5.4 Market entry strategies
Chapter 4 Amyotrophic Lateral Sclerosis Treatment Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Regional network map
4.4.2 Company market position analysis
4.4.3 Company market share, by region
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Company market position analysis
4.6 Supplier Ranking
Chapter 5 Amyotrophic Lateral Sclerosis Treatment Market: Treatment Estimates and Trend Analysis
5.1 Definitions & Scope
5.2 Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Amyotrophic Lateral Sclerosis Treatment Market, by Treatment, 2015 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
5.5.1 Medication Market
5.5.1.1 Medication Market, 2015 to 2026 (USD Million)
5.5.2 Stem Cell Transplant Market
5.5.2.1 Stem Cell Transplant Market, 2015 to 2026 (USD Million)
5.5.3 Others Market
5.5.3.1 Others Market, 2015 to 2026 (USD Million)
Chapter 6 Amyotrophic Lateral Sclerosis Treatment Market: distribution channel Estimates and Trend Analysis
6.1 Definitions & Scope
6.2 Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Amyotrophic Lateral Sclerosis Treatment Market, by distribution channel, 2015 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
6.5.1 Hospital Pharmacies Market
6.5.1.1 Hospital Pharmacies Market, 2015 to 2026 (USD Million)
6.5.2 Retail Pharmacies Market
6.5.2.1 Retail Pharmacies Market, 2015 to 2026 (USD Million)
6.5.3 Others Market
6.5.3.1 Others Market, 2015 to 2026 (USD Million)
Chapter 7 Amyotrophic Lateral Sclerosis Treatment Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2018
7.2.1 North America
7.2.2 Europe
7.2.3 Latin America
7.2.4 Asia Pacific
7.2.5 Middle East & Africa
7.3 Market Share Analysis by Country, 2018
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe
7.3.2.1 UK
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Latin America
7.3.3.1 Brazil
7.3.3.2 Mexico
7.3.3.3 Argentina
7.3.4 Asia Pacific
7.3.4.1 Japan
7.3.4.2 China
7.3.4.3 India
7.3.4.4 South Korea
7.3.4.5 Singapore
7.3.4.6 Australia
7.3.5 Middle east & Africa
7.3.5.1 South africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Latin America
7.4.4 Asia Pacific
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
7.5.1 North America
7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2 Europe
7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.2 UK
7.5.2.2.1 UK Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.3 Latin America
7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.3.2 Brazil
7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.3.3 Mexico
7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.3.4 Argentina
7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4 Asia Pacific
7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.2 Japan
7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.3 China
7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.4 India
7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.5 South Korea
7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.6 Singapore
7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.4.7 Australia
7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.5 Middle east & Africa
7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
7.5.5.4 UAE
7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 Mitsubishi Tanabe Pharma Corporation
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Otsuka Pharmaceutical Co., Ltd.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 BrainStorm Therapeutics
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Biogen Inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Corestem
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 AB Science
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 F.Hoffmann-La Roche AG
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Biohaven Pharmaceutical
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Sun Pharmaceutical
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Ionis Pharmaceuticals, Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
List of Tables Table 1 List of key distributors and channel partners Table 2 List of key emerging companies'/technology disruptors/innovators Table 3 Global amyotrophic lateral sclerosis treatment market, by region, 2015 - 2026 (USD Million) Table 4 Global amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 5 Global amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 6 North America amyotrophic lateral sclerosis treatment market, by country, 2015 - 2026 (USD Million) Table 7 North America amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 8 North America amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 9 U.S. amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 10 U.S. amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 11 Canada amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 12 Canada amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 13 Europe amyotrophic lateral sclerosis treatment market, by country, 2015 - 2026 (USD Million) Table 14 Europe amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 15 Europe amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 16 Germany amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 17 Germany amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 18 UK amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 19 UK amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 20 France amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 21 France amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 22 Spain amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 23 Spain amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 24 Italy amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 25 Italy amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 26 Russia amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 27 Russia amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 28 Asia Pacific amyotrophic lateral sclerosis treatment market, by country, 2015 - 2026 (USD Million) Table 29 Asia Pacific amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 30 Asia Pacific amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 31 Japan amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 32 Japan amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 33 China amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 34 China amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 35 India amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 36 India amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 37 South Korea amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 38 South Korea amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 39 Singapore amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 40 Singapore amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 41 Australia amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 42 Australia amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 43 Latin America amyotrophic lateral sclerosis treatment market, by country, 2015 - 2026 (USD Million) Table 44 Latin America amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 45 Latin America amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 46 Brazil amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 47 Brazil amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 48 Mexico amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 49 Mexico amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 50 Argentina amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 51 Argentina amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 52 MEA amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 53 MEA amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 54 South Africa amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 55 South Africa amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 56 Saudi Arabia amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 57 Saudi Arabia amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Table 58 UAE amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Table 59 UAE amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million)
List of Figures Fig. 1 Amyotrophic lateral sclerosis treatment market segmentation Fig. 2 Market research process Fig. 3 Information procurement Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Value chain based sizing & forecasting Fig. 7 QFD modelling for market share assessment Fig. 8 Amyotrophic lateral sclerosis treatment market snapshot (2018) Fig. 9 Competitive insights (2018) Fig. 10 Parent market outlook Fig. 11 Related/ancillary market outlook Fig. 12 Penetration and growth prospect mapping Fig. 13 Amyotrophic lateral sclerosis treatment market driver impact Fig. 14 Amyotrophic lateral sclerosis treatment market restraint impact Fig. 15 Amyotrophic lateral sclerosis treatment industry challenges Fig. 16 Porter's five forces analysis Fig. 17 SWOT analysis, by factor (Political & legal, economic and technological) Fig. 18 Strategic alliance analysis Fig. 19 Recent developments & impact analysis, by key market participants Fig. 20 Key company market share analysis, 2018 Fig. 21 Company market share/ranking, by region Fig. 22 Company market position analysis Fig. 23 Supplier ranking Fig. 24 Amyotrophic lateral sclerosis treatment market share analysis, by treatment, 2018 & 2026 (%) Fig. 25 Segment dashboard Fig. 26 Global amyotrophic lateral sclerosis treatment market, by treatment, 2015 - 2026 (USD Million) Fig. 27 Medication market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 28 Stem Cell Transplant market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 29 Others market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 30 Amyotrophic lateral sclerosis treatment market share analysis, by distribution channel, 2018 & 2026 (%) Fig. 31 Segment dashboard Fig. 32 Global amyotrophic lateral sclerosis treatment market, by distribution channel, 2015 - 2026 (USD Million) Fig. 33 Hospital pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 34 Retail pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 35 Others market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 36 Amyotrophic lateral sclerosis treatment market: Snapshot, 2018 Fig. 37 North America amyotrophic lateral sclerosis treatment market share and leading players, 2018 Fig. 38 Europe amyotrophic lateral sclerosis treatment market share and leading players, 2018 Fig. 39 Asia Pacific amyotrophic lateral sclerosis treatment market share and leading players, 2018 Fig. 40 Latin America amyotrophic lateral sclerosis treatment market share and leading players, 2018 Fig. 41 Middle East and Africa amyotrophic lateral sclerosis treatment market share and leading players, 2018 Fig. 42 North America amyotrophic lateral sclerosis treatment market share analysis by country, 2018 Fig. 43 Europe amyotrophic lateral sclerosis treatment market share analysis by country, 2018 Fig. 44 Asia Pacific amyotrophic lateral sclerosis treatment market share analysis by country, 2018 Fig. 45 Latin America amyotrophic lateral sclerosis treatment market share analysis by country, 2018 Fig. 46 Middle East and Africa amyotrophic lateral sclerosis treatment market share analysis by country, 2018 Fig. 47 North America SWOT analysis, by factor (political & legal, economic and technological) Fig. 48 Europe SWOT analysis, by factor (political & legal, economic and technological) Fig. 49 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological) Fig. 50 Latin America SWOT analysis, by factor (political & legal, economic and technological) Fig. 51 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological) Fig. 52 North America amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 53 U.S. amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 54 Canada amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 55 Europe amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 56 UK amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 57 Germany amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 58 Spain amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 59 France amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 60 Italy amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 61 Russia amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 62 Asia Pacific amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 63 China amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 64 Japan amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 65 India amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 66 South Korea amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 67 Singapore amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 68 Latin America amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 69 Brazil amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 70 Mexico amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 71 Argentina amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 72 Middle East and Africa amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 73 South Africa amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 74 Saudi Arabia amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million) Fig. 75 UAE amyotrophic lateral sclerosis treatment market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
